Shareholder Alert: Robbins LLP Announces That Voyager Therapeutics, Inc. (VYGR) is Being Sued for Misleading ShareholdersBusiness Wire • 01/25/21
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Voyager Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmBusiness Wire • 01/25/21
VYGR EQUITY ALERT: Rosen Law Firm Announces Filing of Federal Securities Class Action Lawsuit Against Voyager Therapeutics, Inc. – VYGRBusiness Wire • 01/25/21
Pomerantz Law Firm Announces the Filing of a Class Action against Voyager Therapeutics, Inc. and Certain Officers - VYGRPRNewsWire • 01/23/21
Is the Options Market Predicting a Spike in Voyager (VYGR) Stock?Zacks Investment Research • 01/11/21
Voyager Therapeutics (VYGR) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/09/20
Voyager Therapeutics Announces Third Quarter 2020 Financial Results and Corporate UpdatesGlobeNewsWire • 11/09/20
Voyager Therapeutics (VYGR) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/28/20
Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources OfficerGlobeNewsWire • 09/14/20
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene TherapyThe Motley Fool • 09/11/20
Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson’s DiseaseGlobeNewsWire • 09/11/20
Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson's DiseasePRNewsWire • 09/11/20
Voyager Therapeutics Announces Upcoming Presentations at the International Parkinson and Movement Disorder Society Virtual Congress 2020GlobeNewsWire • 09/03/20
Voyager Therapeutics Announces Second Quarter 2020 Financial Results and Corporate UpdatesGlobeNewsWire • 08/10/20
Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor ConferencesGlobeNewsWire • 08/03/20
Voyager Therapeutics Provides Update on AbbVie Vectorized Antibody CollaborationsGlobeNewsWire • 08/03/20